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INVITED BASIC SCIENCE REVIEW
BACKGROUND
The flow of blood to organs is regulated by
changes in the diameter of the blood vessels. Because
the flow through a vessel is directly related to the
radius3, small changes in the diameter can have marked
changes in flow.1 The diameter of the blood vessels is
dependent on a dynamic interaction between two cell
types: the endothelial cells and the smooth muscle
cells. The endothelium is a fragile monolayer of cells
on the inner surface of the vessel. The endothelial cells
are exposed to a variety of events, including the
mechanical forces of pressure and flow (shear stress),
drugs, hormones, and toxins (Fig 1).
Our understanding of endothelial cell function,
and a core principle of vascular biology, is based 
on a relatively simple observation. Furchgott and
Zawadzki2 showed that strips of blood vessels, in
which the endothelial layer was present, relaxed in
response to acetylcholine. However, if the endothelial
layer were removed, the blood vessels then contract-
ed in response to acetylcholine. They took their
observations one step further and placed a vessel with
an intact endothelium next to a vessel without
endothelium. In this case, when acetylcholine was
added, the vessel without endothelium then relaxed in
response to acetylcholine. On the basis of these exper-
iments, they proposed that the stimulation of the
endothelium with acetylcholine led to the production
of a soluble substance that caused muscle relaxation.
They named this substance endothelium-derived
relaxing factor. It took another 7 years to identify this
substance as the simple gas nitric oxide (NO).1 Since
then, it has been shown that the endothelium can
produce a variety of other substances, which in turn
effect smooth muscle responses.
PHYSIOLOGY OF CONTRACTION
Although the endothelium has an important role
in the transduction of stimuli from the blood inter-
face, it is the underlying smooth muscle cells that per-
form the work of maintaining tone. The smooth mus-
cle in the media of the vessel controls the dynamic cal-
iber of the vessel by the state of contraction or
relaxation of the muscle cells. Our understanding of
the mechanisms of contraction in well-ordered mus-
cle cells, such as cardiac or skeletal muscle, is clearer
than our understanding of smooth muscle. The
smooth muscle is a syncytium of spindle-shaped cells.
Although the internal structure of smooth muscle is
not completely defined, it has best been described as
containing four separate domains. The first is the con-
tractile domain, which contains the thick filaments
(myosin), the thin filaments (α-actin), and the thin fil-
ament regulatory proteins (calponin, caldesmon,
tropomyosin, and small heat shock proteins). The sec-
ond domain is the cytoskeletal domain, which con-
tains β–non-muscle actin and the intermediate fila-
ments (desmin and vimentin). The contractile and
cytoskeletal domains are connected at two other
domains: the focal contact points on the membrane,
dense plaques, and the focal contact points inside the
cell, dense bodies. Thus, these focal contact points
may serve as regulatory centers where the contractile
and cytoskeletal domains converge.
Our understanding of vascular smooth muscle
physiology begins with the events that occur when a
contractile agonist, such as norepinephrine, interacts
with receptors on the membrane of the cell. This ini-
tiates a cascade of signals, the first of which is an
increase in the calcium concentration inside the cells.
This increase in calcium activates a kinase (myosin
light chain kinase) that phosphorylates a regulatory
subunit on the myosin motor protein (the regulato-
ry myosin light chain), leading to a conformational
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change in the head of the myosin molecule and the
consumption of energy. This results in the formation
and cycling of cross-bridges between actin and
myosin, the shortening of the muscle, and the gener-
ation of force (Fig 2). Because this mechanism
involves activation of the thick filament, myosin, it
has been referred to a thick filament regulation of
smooth muscle contraction. More recently, other
kinases have been implicated in the thick filament
regulation of muscle contraction, such as Rho kinase
(ROK). ROK has been shown to phosphorylate both
the myosin light chains and the myosin light chain
phosphatase. When ROK phosphorylates the myosin
light chain phosphatase, it leads to inactivation of the
phosphatase. In essence, the thick filament regulation
of smooth muscle contraction depends on the state
of phosphorylation or dephosphorylation of the reg-
ulatory myosin light chains (Fig 3).
Unlike cardiac or skeletal muscles, vascular
smooth muscle is able to maintain force for long peri-
ods of time. One of the confounding questions in
smooth muscle physiology is that this sustained phase
of muscle contraction is associated with calcium con-
centrations, myosin light chain phosphorylation, and
levels of energy consumption that are near those
found in muscles that are not contracted (Fig 4). This
has been referred to as the latch state, and although
models have been described to account for the latch
state,3 the models do not explain all of the existing
data. Thus, many investigators have proposed other
regulatory mechanisms for the sustained phase of
muscle contraction. Most of these mechanisms are
based on proteins that are associated with the thin fil-
ament actin, and thus, this has been referred to as thin
filament regulation of muscle contraction. For exam-
ple, caldesmon is an actin-associated protein that,
when phosphorylated, dissociates from actin, allowing
actin and myosin to interact and form cross-bridges.
Other thin filament proteins that may regulate con-
traction include calponin, tropomyosin, and the small
heat shock protein, HSP27. It is likely that multiple,
and possibly redundant, mechanisms are involved in
the initiation and maintenance of force in the vascular
smooth muscle.
PHYSIOLOGY OF RELAXATION
There are two ways in which contracted muscles
decrease force or relax. The first involves the
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Fig 1. The blood vessel. Endothelial cells (green ovals) are exposed to a variety of stimuli,
including mechanical forces of pressure and flow (shear stress), drugs, hormones, and toxins.
Endothelial cells transduce these stimuli and respond by sending messages to smooth muscle
cells (red ovals), which leads to responses such as contraction, relaxation, proliferation, migra-
tion, or synthesis of proteins.
removal of a contractile agonist (passive relaxation).
Alternatively, in the continued presence of a con-
tractile agonist, substances that activate other signal-
ing pathways, such as NO and prostacyclin, and that
will cause relaxation (active relaxation). NO leads 
to increases in cyclic guanosine monophosphate
(cGMP), whereas prostacyclin leads to increases in
cyclic adenosine monophosphate (cAMP). cGMP
and cAMP then activate cGMP-dependent protein
kinase and cAMP-dependent protein kinase, respec-
tively. Kinases are enzymes that phosphorylate spe-
cific substrate proteins, and multiple substrate pro-
teins have been implicated in muscle relaxation
(Table I). Most of these putative substrate proteins
affect intracellular calcium concentrations or myosin
light chain phosporylation. However, there is con-
siderable data that suggest that mechanisms other
than lowering intracellular calcium or myosin light
chain phosphorylation are involved in active relax-
ation, including the observation that both intracel-
lular calcium and myosin light chain phosphoryla-
tion are near basal levels during the sustained phase
of muscle contraction (Fig 4).
Our laboratory has recently shown that one of the
proteins that is phosphorylated during active relaxation
is a small heat shock–related protein, HSP20.4 More
direct evidence that suggests that this protein is impor-
tant in the relaxation of muscle is that phosphorylated
peptide analogues of HSP20 inhibit muscle contrac-
tion.5 Although the specific functions of heat shock
proteins in muscle cells are not known, heat shock pro-
teins often function as “molecular chaperones” and
directly modulate protein interactions. There are con-
siderable amounts of two of the small heat shock pro-
teins, HSP20 and HSP27, in muscle cells, and both of
these proteins are associated with actin. Thus, the small
heat shock proteins may have an important role in the
regulation of smooth muscle physiology.
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Fig 2. Myosin (yellow) is a motor protein that, when activated, leads to formation of cross-
bridges with actin and sliding of actin thin filaments to a more shortened configuration (thick
filament regulation). Actin (thin yellow line) is associated with a variety of proteins, including
tropomyosin, caldesmon, calponin, and small heat shock proteins, which may be important in
maintenance of force (thin filament regulation). We propose a model for maintenance of force
in smooth muscle (tethering domain model) in which phosphorylated HSP27 (P-HSP27;
orange oval) tethers actin with a specific but unknown domain protein (green squares). During
relaxation, phosphorylated HSP20 (P-HSP20, purple triangle) directly interacts with phos-
phorylated HSP27, thus destabilizing interaction of actin with domain protein.
PROPOSED MODEL
On the basis of this new information, we propose
a model for the maintenance of force in vascular
smooth muscle: the tethering domain model (Fig 2).
This model suggests that the small heat shock pro-
teins stabilize and destabilize force at a specific
domain in the muscle cell. It is possible that HSP27
stabilizes actin with a specific, but yet unknown,
structural element in the muscle cell. One candidate
for this structural element is the dense bodies and
dense plaques that are strategically located where the
structural rearrangements that are required for
shortening of muscle cells may occur. Because the
activation of relaxation pathways leads to increases in
the phosphorylation of HSP20, the phosphorylated
HSP20 might directly interact with HSP27, leading
to a conformational change in the HSP27 molecule.
This would result in a dissociation of HSP27 and
actin from the specific tethering attachment and a
relaxation of the muscle cells. An alternate, but also
untested, model to explain the dynamic cellular
rearrangements that occur with muscle contraction
and relaxation is that there are changes in actin fila-
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Fig 3. Thick filament regulation of smooth muscle con-
traction. Increases in calcium (Ca2+) activate myosin light
chain kinase (MLCK), which phosphorylates regulatory
light chains (MLC) on the myosin motor molecule.
Regulatory light chains are dephosphorylated by myosin
light chain phosphatase (MLC Ppase), which has recently
been shown to be inhibited by Rho-activated kinase
(ROK). Thick filament regulation of smooth muscle con-
traction assumes that force is dependent on the phospho-
rylation state of regulatory myosin light chains.
Fig 4. Relationship between calcium concentrations,
myosin light chain phosphorylation, and force develop-
ment in vascular smooth muscle contraction. Stimulation
of vascular smooth muscles with a contractile agonist (A)
leads to rapid increases in calcium concentrations (dotted
line) followed by increases in phosphorylation of regula-
tory myosin light chains (dashed lines) and development of
force (solid line). During the sustained phase of muscle
contraction, calcium concentrations and myosin light
chain phosphorylation return to near basal levels.
Table I. Mechanisms of cyclic nucleotide-depen-
dent relaxation
Substrate Mechanism of action
Kca channels Repolarize muscle membrane
L-type Ca2+ channels Promote release of Ca2+
IP3 receptor, phospholamban Inhibits release of Ca2+ from
intracellular stores
Myosin light chain kinase Inhibits myosin light chain 
phosphorylation
MLC20 phosphatase Dephosphorylates MLC20
HSP20 Dissociates relaxation and 
the Ca2+-dependent 
MLC20 pathway
Possible cyclic nucleotide-dependent protein kinase substrates in
smooth muscle include: plasma membrane ion channels (Kca or L-
type Ca2+ channels; IP3; phospholamban, which activates the
adenosine triphosphatase of the endoplasmic reticulum, leading to
a decrease in intracellular Ca2+); myosin light chain kinase, which
reduces its affinity for Ca2+, resulting in decreased phosphorylation
of the MLC20; or the MLC20 phosphatase, which dephophorylates
MLC20. These putative cyclic nucleotide-dependent protein kinase
substrates all mediate smooth muscle relaxation through the
decrease of either intracellular calcium concentrations or MLC20
phosphorylation. However, increases in the phosphorylation of the
small heat shock–related protein, HSP20, may dissociate relaxation
from the Ca2+ dependent MLC20 pathway.
KCa, Calcium-dependent potassium channel; Ca2+, calcium; IP3,
inositol 1,4,5-triphosphate receptor; MLC20, myosin light chains;
HSP20, heat shock protein 20.
ment dynamics (actin polymerization and depoly-
merization). Because both HSP27 and HSP20 mod-
ulate actin filament dynamics, this model is also
plausible.
BLOOD VESSEL TONE AND VASCULAR
REMODELING
Two processes have been implicated in the
chronic changes in vessel diameter that occur with
atherosclerosis and restenosis after angioplasty:
intimal thickening and remodeling. Smooth muscle
cell migration, proliferation, and the production of
matrix molecules have been implicated in intimal
thickening. The activation of cyclic nucleotide-
dependent signaling pathways has been shown to
inhibit vascular smooth muscle proliferation and
migration in vitro and in vivo. Remodeling refers
to the changes in artery wall structure in response
to hemodynamic forces. Remodeling maintains
shear stress and wall tension within a physiologic
range. There is growing evidence that it is the fail-
ure of normal remodeling, rather than the accumu-
lation of intimal plaque, that leads to both athero-
sclerosis and restenosis after angioplasty. The spe-
cific mechanisms that account for physiologic and
pathologic remodeling are not known. However, it
is likely that endothelial-derived NO and the
impact of NO on the smooth muscle is important
in this process. Thus, the same signaling events that
are activated during smooth muscle relaxation may
be important in the modulation of chronic changes
in vessel caliber.
FUTURE QUESTIONS
The possibility that stress proteins regulate smooth
muscle physiology suggests molecular mechanisms for
the association between stress and vascular diseases,
such as hypertension and atherosclerosis. Future stud-
ies are needed to determine whether there is a rela-
tionship between the processes that regulate acute
changes in vessel caliber with the processes that regu-
late chronic changes in caliber (remodeling). In addi-
tion, studies are needed to determine the mechanisms
by which the heat shock proteins modulate vasomotor
tone. The answer to these questions will lead to a bet-
ter understanding of vascular physiology and to more
direct approaches to the treatment of vascular diseases.
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